Bayer shares rose as much as 15% on Tuesday after the U.S. solicitor general backed the company’s bid to get the Supreme ...

The company said the government’s support would be significant and could help limit tens of thousands of lawsuits.

President Donald Trump's administration urged the U.S. Supreme Court on Monday to take up Bayer’s bid to curtail thousands of lawsuits claiming its Roundup weedkiller causes cancer, backing the ...

IBP-9414 will be the first live biotherapeutic product globally, according to officials at Infant Bacterial Therapeutics in Stockholm.

Bayer is deploying GenAI tools at scale while many corporates struggle to find ROI on AI. The difference may lie in a 12-year ...

Having suffered defeat by Newcastle United at the weekend, Manchester City will be looking to return to winning ways when Bayer Leverkusen visit the Etihad Stadium on Tuesday evening. Will Pep ...

HYRNUO is a reversible kinase inhibitor of human epidermal growth factor receptor 2 (HER2). In vitro, HYRNUO inhibited the phosphorylation of HER2, downstream signaling in cancer cells with HER2 ...

Q3 2025 Earnings Call Transcript November 20, 2025 Evogene Ltd. beats earnings expectations. Reported EPS is $-0.31, ...

A new oral HER2-directed breast cancer therapy from Bayer AG, and its companion diagnostic from Thermo Fisher Scientific Inc., have been approved by the U.S. FDA. Hyrnuo (sevabertinib), a reversible ...

The accelerated FDA approval of Bayer's Hyrnuo covers treatment of advanced cases of non-small cell lung cancer with HER2 ...

Bayer (BAYZF) stock is in focus as the FDA grants accelerated approval for the company's tumor drug Hyrnuo in non-squamous ...

The U.S. Food and Drug Administration on Wednesday approved Bayer's drug for patients with a type of lung cancer. The drug, ...